000 01173 a2200289 4500
005 20250513225441.0
264 0 _c20010215
008 200102s 0 0 eng d
022 _a0149-5992
024 7 _a10.2337/diacare.23.12.1723
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCooper, M E
245 0 0 _aLong-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy: response to Tarnow et al.
_h[electronic resource]
260 _bDiabetes care
_cDec 2000
300 _a1723-4 p.
_bdigital
500 _aPublication Type: Comment; Editorial
650 0 4 _aAngiotensin-Converting Enzyme Inhibitors
_xtherapeutic use
650 0 4 _aAntihypertensive Agents
_xtherapeutic use
650 0 4 _aCalcium Channel Blockers
_xtherapeutic use
650 0 4 _aDiabetes Mellitus, Type 1
_xdrug therapy
650 0 4 _aDiabetic Nephropathies
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aLisinopril
_xtherapeutic use
650 0 4 _aNisoldipine
_xtherapeutic use
773 0 _tDiabetes care
_gvol. 23
_gno. 12
_gp. 1723-4
856 4 0 _uhttps://doi.org/10.2337/diacare.23.12.1723
_zAvailable from publisher's website
999 _c11068726
_d11068726